|
Subsequent Events - Additional Information (Detail) (Subsequent Event, USD $)
In Millions, except Share data, unless otherwise specified |
0 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
|
Jul. 26, 2013
|
Jul. 12, 2013
First Tranche
|
Jul. 12, 2013
Fda Clearance
|
Jul. 12, 2013
Second Ent Laser
|
Jul. 12, 2013
Third Ent Laser
|
Jul. 12, 2013
Valam Warrant
|
Jun. 30, 2013
Valam Warrant
|
|
| Subsequent Event [Line Items] | |||||||
| Maximum stock offering price | $ 30 | ||||||
| Warrants issued to purchase common stock | 165,000 | ||||||
| Warrants price of warrants | 6.00 | ||||||
| Vesting of warrants | 30,000 | 55,000 | 40,000 | 40,000 | |||
| ENT laser revenues required during a 12-month period | $ 5 | $ 10 | |||||
| Plan expiration date | Jul. 14, 2020 | ||||||
| X | ||||||||||
|
- Definition
Class Of Warrant Or Right Warrants Exercisable No definition available.
|
| X | ||||||||||
|
- Definition
Maximum Stock Offering Price No definition available.
|
| X | ||||||||||
|
- Definition
The exercise price of each class of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The specified number of securities that each class of warrants or rights outstanding give the holder the right but not the obligation to purchase from the issuer at a specific price, on or before a certain date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date the equity-based award expires, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|